196 related articles for article (PubMed ID: 22375429)
21. Aqueous film coating to reduce recrystallization of guaifenesin from hot-melt extruded acrylic matrices.
Bruce CD; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Drug Dev Ind Pharm; 2010 Feb; 36(2):218-26. PubMed ID: 19877992
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of coat uniformity and taste-masking efficiency of irregular-shaped drug particles coated in a modified tangential spray fluidized bed processor.
Xu M; Heng PW; Liew CV
Expert Opin Drug Deliv; 2015; 12(10):1597-606. PubMed ID: 26051826
[TBL] [Abstract][Full Text] [Related]
23. Formulation and characterization of taste masked ondansetron-magnesium aluminum silicate adsorption systems.
Kharb V; Saharan VA; Kharb V; Jadhav H; Purohit S
Drug Dev Ind Pharm; 2016 Aug; 42(8):1291-9. PubMed ID: 26641930
[TBL] [Abstract][Full Text] [Related]
24. Delayed release film coating applications on oral solid dosage forms of proton pump inhibitors: case studies.
Missaghi S; Young C; Fegely K; Rajabi-Siahboomi AR
Drug Dev Ind Pharm; 2010 Feb; 36(2):180-9. PubMed ID: 20070183
[TBL] [Abstract][Full Text] [Related]
25. Cholorpheniramine tannate complexes: physicochemical, chemometric, and taste masking evaluation.
Rahman Z; Zidan AS; Khan SR; Reddy IK; Khan MA
Int J Pharm; 2012 Oct; 436(1-2):582-92. PubMed ID: 22868234
[TBL] [Abstract][Full Text] [Related]
26. Design, evaluation and optimization of taste masked clarithromycin powder.
Ntemi PV; Walker RB; Khamanga SMM
Pharmazie; 2019 Dec; 74(12):721-727. PubMed ID: 31907110
[TBL] [Abstract][Full Text] [Related]
27. Granulation of core particles suitable for film coating by agitation fluidized bed I. Optimum formulation for core particles and development of a novel friability test method.
Hamashita T; Nakagawa Y; Aketo T; Watano S
Chem Pharm Bull (Tokyo); 2007 Aug; 55(8):1169-74. PubMed ID: 17666839
[TBL] [Abstract][Full Text] [Related]
28. Taste masking of bitter drug powder without loss of bioavailability by heat treatment of wax-coated microparticles.
Sugao H; Yamazaki S; Shiozawa H; Yano K
J Pharm Sci; 1998 Jan; 87(1):96-100. PubMed ID: 9452976
[TBL] [Abstract][Full Text] [Related]
29. Effects of nano zinc oxide and nano chitosan on the taste masking paracetamol granules.
Rashidi T; Shakeri A
Drug Dev Ind Pharm; 2024 Jun; 50(6):495-510. PubMed ID: 38718260
[TBL] [Abstract][Full Text] [Related]
30. Optimum spray congealing conditions for masking the bitter taste of clarithromycin in wax matrix.
Yajima T; Umeki N; Itai S
Chem Pharm Bull (Tokyo); 1999 Feb; 47(2):220-5. PubMed ID: 10071855
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of poly(styrene-alt-maleic anhydride)-ethanol as enteric coating material.
Lai X; Sun C; Tian H; Zhao W; Gao L
Int J Pharm; 2008 Mar; 352(1-2):66-73. PubMed ID: 18054184
[TBL] [Abstract][Full Text] [Related]
32. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
Sauer D; Zheng W; Coots LB; McGinity JW
Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
[TBL] [Abstract][Full Text] [Related]
33. Preparation and in vitro dissolution profile of zidovudine loaded microspheres made of Eudragit RS 100, RL 100 and their combinations.
Nath B; Nath LK; Kumar P
Acta Pol Pharm; 2011; 68(3):409-15. PubMed ID: 21648196
[TBL] [Abstract][Full Text] [Related]
34. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.
Schilling SU; Bruce CD; Shah NH; Malick AW; McGinity JW
Int J Pharm; 2008 Sep; 361(1-2):158-68. PubMed ID: 18582547
[TBL] [Abstract][Full Text] [Related]
35. Application of melt granulation technology to enhance stability of a moisture sensitive immediate-release drug product.
Kowalski J; Kalb O; Joshi YM; Serajuddin AT
Int J Pharm; 2009 Oct; 381(1):56-61. PubMed ID: 19486933
[TBL] [Abstract][Full Text] [Related]
36. Granulation of core particles suitable for film coating by agitation fluidized bed II. A proposal of a rapid dissolution test for evaluation of bitter taste of ibuprofen.
Hamashita T; Matsuzaki M; Ono T; Ono M; Tsunenari Y; Aketo T; Watano S
Chem Pharm Bull (Tokyo); 2008 Jul; 56(7):883-7. PubMed ID: 18591795
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of powder, solution and suspension layering for the preparation of enteric coated pellets.
Kovacevic J; Mladenovic A; Djuris J; Ibric S
Eur J Pharm Sci; 2016 Mar; 85():84-93. PubMed ID: 26796145
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of physico-mechanical properties of drug-excipients agglomerates obtained by crystallization.
Maghsoodi M; Tajalli Bakhsh AS
Pharm Dev Technol; 2011 Jun; 16(3):243-9. PubMed ID: 20175665
[TBL] [Abstract][Full Text] [Related]
39. Optimum heat treatment conditions for masking the bitterness of the clarithromycin wax matrix.
Yajima T; Itai S; Takeuchi H; Kawashima Y
Chem Pharm Bull (Tokyo); 2003 Nov; 51(11):1223-6. PubMed ID: 14600362
[TBL] [Abstract][Full Text] [Related]
40. Effect of surfactants or a water soluble polymer on the crystal transition of clarithromycin during a wet granulation process.
Nozawa K; Iwao Y; Noguchi S; Itai S
Int J Pharm; 2015 Nov; 495(1):204-217. PubMed ID: 26325306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
